• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估原代人肝细胞的长期功能维持情况,以预测体外药物诱导的肝毒性。

Assessment of long-term functional maintenance of primary human hepatocytes to predict drug-induced hepatoxicity in vitro.

机构信息

Department of Anesthesiology, Renji Hospital, Jiaotong University School of Medicine, Shanghai, China.

Department of Molecular Oncology, Eastern Hepatobiliary Surgery Hospital & National Center of Liver Cancer, Second Military Medical University, Shanghai, China.

出版信息

Arch Toxicol. 2021 Jul;95(7):2431-2442. doi: 10.1007/s00204-021-03050-y. Epub 2021 Apr 14.

DOI:10.1007/s00204-021-03050-y
PMID:33852043
Abstract

Hepatocytes are the main cell components of the liver and perform metabolic, detoxification, and endocrine functions. Functional hepatocytes are of great value in drug development, toxicity evaluation, and cell therapy for liver diseases. In recent years, an increasing number of in vitro models have been developed to screen drugs and test their toxicity. However, maintaining hepatocyte function in vitro for a long time is a serious challenge. Even freshly isolated liver cells cultured for a short time may lose function via spontaneous dedifferentiation. Thus, novel cell culture systems allowing extended hepatocyte maintenance and more predictive long-term in vitro studies are required. In this study, we developed a conditioned culture system composed of a small-molecule combination that can maintain hepatocyte morphology and functions over the long term. Two-month culture of primary human hepatocytes showed that the conditioned medium was able to stably preserve hepatic functions such as albumin and α-antitrypsin secretion, hepatic transport activity, urea synthesis, and ammonia elimination. Furthermore, this culture model can be used to assess drug-induced hepatotoxicity in vitro. In summary, our work suggests a feasible approach to maintain hepatocyte function in vitro and proposes a promising model for long-term toxicological studies and drug development.

摘要

肝细胞是肝脏的主要细胞成分,具有代谢、解毒和内分泌功能。功能正常的肝细胞在药物开发、毒性评估和肝脏疾病的细胞治疗中具有重要价值。近年来,已经开发出越来越多的体外模型来筛选药物并测试其毒性。然而,长时间在体外维持肝细胞功能是一个严峻的挑战。即使是短时间培养的新鲜分离的肝细胞也可能通过自发去分化而失去功能。因此,需要开发新型的细胞培养系统,以允许延长肝细胞的维持时间并进行更具预测性的长期体外研究。在本研究中,我们开发了一种由小分子组合组成的条件培养系统,该系统能够长期维持肝细胞的形态和功能。对原代人肝细胞进行两个月的培养表明,该条件培养基能够稳定地保持白蛋白和α-抗胰蛋白酶分泌、肝转运活性、尿素合成和氨消除等肝脏功能。此外,这种培养模型可用于体外评估药物诱导的肝毒性。总之,我们的工作提出了一种可行的体外维持肝细胞功能的方法,并为长期毒理学研究和药物开发提出了一种有前途的模型。

相似文献

1
Assessment of long-term functional maintenance of primary human hepatocytes to predict drug-induced hepatoxicity in vitro.评估原代人肝细胞的长期功能维持情况,以预测体外药物诱导的肝毒性。
Arch Toxicol. 2021 Jul;95(7):2431-2442. doi: 10.1007/s00204-021-03050-y. Epub 2021 Apr 14.
2
Maintenance of Primary Hepatocyte Functions In Vitro by Inhibiting Mechanical Tension-Induced YAP Activation.通过抑制机械张力诱导的 YAP 激活来维持原代肝细胞的体外功能。
Cell Rep. 2019 Dec 3;29(10):3212-3222.e4. doi: 10.1016/j.celrep.2019.10.128.
3
Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture.药物代谢活性是长期培养过程中选择肝细胞的关键细胞内在决定因素。
Stem Cell Res Ther. 2022 Mar 12;13(1):104. doi: 10.1186/s13287-022-02776-5.
4
Generation of hepatic spheroids using human hepatocyte-derived liver progenitor-like cells for hepatotoxicity screening.使用人源性肝祖细胞样细胞生成肝球体用于肝毒性筛选。
Theranostics. 2019 Sep 18;9(22):6690-6705. doi: 10.7150/thno.34520. eCollection 2019.
5
Establishment of ornithine transcarbamylase deficiency-derived primary human hepatocyte with hepatic functions.建立具有肝功能的精氨酸转氨甲酰酶缺乏症源性原代人肝细胞。
Exp Cell Res. 2019 Nov 1;384(1):111621. doi: 10.1016/j.yexcr.2019.111621. Epub 2019 Sep 9.
6
Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing.人Upcyte肝细胞:肝表型特征及急性和长期肝毒性常规检测评估
Toxicol Sci. 2016 Jul;152(1):214-29. doi: 10.1093/toxsci/kfw078. Epub 2016 May 4.
7
Merging bioreactor technology with 3D hepatocyte-fibroblast culturing approaches: Improved in vitro models for toxicological applications.将生物反应器技术与 3D 肝细胞-成纤维细胞培养方法相结合:用于毒理学应用的改进型体外模型。
Toxicol In Vitro. 2011 Jun;25(4):825-32. doi: 10.1016/j.tiv.2011.02.002. Epub 2011 Feb 16.
8
Sensitivities of gel entrapped hepatocytes in hollow fibers to hepatotoxic drug.中空纤维中凝胶包封的肝细胞对肝毒性药物的敏感性。
Toxicol Lett. 2006 Sep 30;166(1):19-26. doi: 10.1016/j.toxlet.2006.05.008. Epub 2006 May 17.
9
Sandwich-cultured hepatocytes: utility for in vitro exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity.夹心培养肝细胞:用于体外探索肝胆药物处置和药物诱导肝毒性的应用。
Expert Opin Drug Metab Toxicol. 2013 May;9(5):589-616. doi: 10.1517/17425255.2013.773973. Epub 2013 Mar 2.
10
New hepatocyte in vitro systems for drug metabolism: metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures.用于药物代谢的新型体外肝细胞系统:代谢能力及在基础研究和药物开发中的应用建议、标准操作程序
Drug Metab Rev. 2003 May-Aug;35(2-3):145-213. doi: 10.1081/dmr-120023684.

引用本文的文献

1
Chemical approaches targeting the hurdles of hepatocyte transplantation: mechanisms, applications, and advances.针对肝细胞移植障碍的化学方法:机制、应用与进展
Front Cell Dev Biol. 2024 Oct 31;12:1480226. doi: 10.3389/fcell.2024.1480226. eCollection 2024.
2
Liver-on-a-Chip Integrated with Label-Free Optical Biosensors for Rapid and Continuous Monitoring of Drug-Induced Toxicity.芯片上的肝脏与无标记光学生物传感器集成,用于快速连续监测药物诱导的毒性。
Small. 2024 Nov;20(48):e2403560. doi: 10.1002/smll.202403560. Epub 2024 Aug 30.
3
Designer cellular spheroids with DNA origami for drug screening.

本文引用的文献

1
Drug induced liver injury: an update.药物性肝损伤:最新进展。
Arch Toxicol. 2020 Oct;94(10):3381-3407. doi: 10.1007/s00204-020-02885-1. Epub 2020 Aug 27.
2
Liver regeneration: biological and pathological mechanisms and implications.肝脏再生:生物学和病理学机制及其意义。
Nat Rev Gastroenterol Hepatol. 2021 Jan;18(1):40-55. doi: 10.1038/s41575-020-0342-4. Epub 2020 Aug 6.
3
Cell Plasticity in Liver Regeneration.肝再生中的细胞可塑性。
利用 DNA 折纸术设计细胞球体用于药物筛选。
Sci Adv. 2024 Jul 19;10(29):eado9880. doi: 10.1126/sciadv.ado9880.
4
In Vitro Models for Studying Chronic Drug-Induced Liver Injury.用于研究慢性药物性肝损伤的体外模型。
Int J Mol Sci. 2022 Sep 28;23(19):11428. doi: 10.3390/ijms231911428.
5
activates the AIM2-caspase-1/-4-GSDMD axis to induce pyroptosis in hepatocytes.激活 AIM2-caspase-1/-4-GSDMD 轴诱导肝细胞发生细胞焦亡。
Virulence. 2022 Dec;13(1):963-979. doi: 10.1080/21505594.2022.2080904.
Trends Cell Biol. 2020 Apr;30(4):329-338. doi: 10.1016/j.tcb.2020.01.007. Epub 2020 Feb 11.
4
Founder cells for hepatocytes during liver regeneration: from identification to application.肝再生过程中肝细胞的起源细胞:从鉴定到应用。
Cell Mol Life Sci. 2020 Aug;77(15):2887-2898. doi: 10.1007/s00018-020-03457-3. Epub 2020 Feb 14.
5
LCAT protects against Lipoprotein-X formation in a murine model of drug-induced intrahepatic cholestasis.LCAT 可防止药物诱导的肝内胆汁淤积症小鼠模型中脂蛋白-X 的形成。
Pharmacol Res Perspect. 2019 Dec 29;8(1):e00554. doi: 10.1002/prp2.554. eCollection 2020 Feb.
6
Maintenance of Primary Hepatocyte Functions In Vitro by Inhibiting Mechanical Tension-Induced YAP Activation.通过抑制机械张力诱导的 YAP 激活来维持原代肝细胞的体外功能。
Cell Rep. 2019 Dec 3;29(10):3212-3222.e4. doi: 10.1016/j.celrep.2019.10.128.
7
Development of an in vitro cholestatic drug-induced liver injury evaluation system using HepG2-hNTCP-C4 cells in sandwich configuration.采用 HepG2-hNTCP-C4 细胞夹心式构建体外胆汁淤积性药物肝损伤评价系统的研究。
Toxicol In Vitro. 2019 Dec;61:104619. doi: 10.1016/j.tiv.2019.104619. Epub 2019 Aug 5.
8
Drug-Induced Liver Injury - Types and Phenotypes.药物性肝损伤——类型与表型
N Engl J Med. 2019 Jul 18;381(3):264-273. doi: 10.1056/NEJMra1816149.
9
Long-term functional maintenance of primary human hepatocytes in vitro.原代人肝细胞体外长期功能维持。
Science. 2019 Apr 26;364(6438):399-402. doi: 10.1126/science.aau7307.
10
Hepatocellular Carcinoma.肝细胞癌
N Engl J Med. 2019 Apr 11;380(15):1450-1462. doi: 10.1056/NEJMra1713263.